Loading...
Loading...
Application 2537759 · Registered
| Application Number | 2537759 |
| Status | Registered |
| Owner | mankind pharma limited |
| Type | trade_mark |
| Filed | 2025-04-08 |
| Registered | 2025-11-17 |
Yes. LINAGLIPTIN MKD is a currently protected Australian trademark. It is enforceable under the Trade Marks Act 1995 (Cth) in Australia.
Key events recorded against this trademark at IP Australia, oldest first.
| Name | mankind pharma limited |
| Country | IN |
This trademark is represented by pipers intellectual property, NZ.
'LINAGLIPTIN MKD' is a protected trademark on the IP Australia register, owned by mankind pharma limited. The application (2537759) was filed on 8 April 2025 and registered on 17 November 2025.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
Australian trademark 2537759 for the mark 'LINAGLIPTIN MKD' in Class 5 is recorded on the IP Australia register as owned by mankind pharma limited. This covers one specific Australian trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the IP Australia records the status of Australian trademark 2537759 for the mark 'LINAGLIPTIN MKD' as protected.
Australian trademark 2537759 for the mark 'LINAGLIPTIN MKD' is registered in Class 5, which covers pharmaceuticals & medical preparations.
Australian trademark 2537759 for the mark 'LINAGLIPTIN MKD' was filed at the IP Australia on 8 April 2025 and registered on 17 November 2025.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence. Local copy last synchronised on 2026-05-03.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.